Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061221/0218 | |
| Pages: | 2 |
| | Recorded: | 09/27/2022 | | |
| Attorney Dkt #: | 85467 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17102456
|
Filing Dt:
|
11/24/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/27/2021
| | | | |
|
Title:
|
ANTI-TUMOR COMPOSITION COMPRISING GM-CSF GENE, Flt3L-TRAIL FUSION GENE, shRNA INHIBITING TGF-ß EXPRESSION, AND shRNA INHIBITING HSP EXPRESSION
|
|
|
Assignee
|
|
|
|
|
| 2ND FLOOR ADMINISTRATION BUILDING, 50-1 YONSEI-RO SEODAEMUN-GU |
| SEOUL, KOREA, REPUBLIC OF 03722 |
|
|
Correspondence name and address
|
| |
MARTIN MOYNIHAN D/B/A PRTSI, INC.
|
| |
CUSTOMER NUMBER 67801
|
| |
232 NW 42ND TER
|
| |
PLANTATION, FL 33317
|
Search Results as of:
06/25/2024 08:05 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
